HLA-A*02:01-POSITIVE
Clinical trials for HLA-A*02:01-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HLA-A*02:01-POSITIVE trials appear
Sign up with your email to follow new studies for HLA-A*02:01-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First patients receive experimental Cancer-Fighting drug
Disease control Recruiting nowThis is the first human study testing a new immune therapy drug called IMC-P115C for people with advanced cancers that have a specific protein marker called PRAME. The trial will enroll 140 participants to check if the drug is safe and shows early signs of working, both alone and…
Matched conditions: HLA-A*02:01-POSITIVE
Phase: PHASE1 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Apr 03, 2026 22:41 UTC
-
First human trial launches for targeted cancer immune therapy
Disease control Recruiting nowThis study is testing a new experimental drug called IMC-R117C for people with advanced colorectal, esophageal, gastric, or ovarian cancers. The drug works by directing the body's immune cells to attack cancer cells that have a specific marker called PIWIL1. Researchers will eval…
Matched conditions: HLA-A*02:01-POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC